INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

For the key trials, our articles and recipes, read the Atherosclerosis & Heart Disease desk →

1,829 studies · page 52 of 77

2025 / Randomized controlled trial

A whole-food, plant-based diet with exercise improved glycaemic control and reduced medication use in individuals with type 2 diabetes.

In a 24-week parallel-arm randomized trial, 169 adults with type 2 diabetes were assigned to an intensive whole-food, plant-based intervention with moderate exercise (PB+Ex) or standard medical care (SMC). Compared with SMC, the PB+Ex intervention resulted in greater HbA1c reductions at week 12 (-22 vs -7 mmol/mol [-2.0% vs -0.7%]; p<0.0001) and week 24 (-16 vs -8 mmol/mol [-1.4% vs -0.7%]; p=0.01). Furthermore, 63% of medicated PB+Ex participants reduced glucose-lowering medications compared to 24% in SMC (p=0.006), and 23% with baseline HbA1c <75 mmol/mol achieved remission. PB+Ex also led to reductions in weight (-2.7 kg; p<0.0001), C-reactive protein (-11 nmol/l; p=0.005), and cardiovascular medication use.

Hanick CJ, Peterson CM, Davis BC, et al. Diabetologia, 2025. PMID 39305340

2025 / Randomized controlled trial subcohort analysis

Accounting for background diet and adherence via biomarkers revealed larger effect sizes for cocoa flavanol intervention outcomes in COSMOS.

Using validated flavanol biomarkers, researchers assessed background diet and adherence in a subcohort of the randomized COcoa Supplement and Multivitamin Outcomes Study. They found 20% of participants had a flavanol background intake as high as the intervention, and about 33% in the intervention arm did not reach expected biomarker levels. Compared with intention-to-treat and per-protocol analyses, biomarker-based analysis showed larger effect sizes: total CVD events HR 0.65 (95% CI: 0.47, 0.89), CVD mortality HR 0.44 (0.20, 0.97), all-cause mortality HR 0.54 (0.37, 0.80), and major CVD events HR 0.48 (0.31, 0.74).

Ottaviani JI, Schroeter H, Bier DM, et al. Food Funct, 2025. PMID 40568979

2025 / 2x2 factorial, double-blind, placebo-controlled randomized clinical trial

Cocoa extract supplementation did not reduce overall incident hypertension in older adults, though it lowered risk in those with baseline systolic BP <120 mm Hg.

In the COSMOS trial, 8,905 older adults free of baseline hypertension were randomized to daily cocoa extract (500 mg/d cocoa flavanols with 80 mg/d [-]-epicatechin) or placebo. Over a median follow-up of 3.4 years, cocoa extract did not significantly reduce incident hypertension overall (7.1 vs 7.4 per 100 person-years; HR 0.96 [95% CI, 0.88-1.05]). However, in subgroup analysis, cocoa extract reduced incident hypertension among participants with baseline systolic BP <120 mm Hg (HR 0.76 [95% CI, 0.64-0.90]), but not among those with baseline systolic BP of 120 to 139 mm Hg (HR 1.05 [95% CI, 0.93-1.18]; P-interaction=0.002).

Hamaya R, Li S, Lau J, et al. Hypertension, 2025. PMID 40832703

2024 / Randomized controlled trial (ancillary analysis)

Prune supplementation for 12 months did not alter glycemic markers or blood lipids in postmenopausal women, and may prevent adverse changes in central adiposity.

An ancillary study of a 12-month RCT evaluated the effects of 50 g/day or 100 g/day prune supplementation compared with a control group in postmenopausal women. Neither 50 g/day nor 100 g/day prunes altered markers of glycemic control or blood lipids after 12 months (all P > 0.05), nor did gynoid percent fat and visceral adipose tissue indices differ significantly between groups. However, android total mass increased by 3.19% ± 5.5% from baseline in the control group, whereas it decreased by 0.02% ± 5.6% in the 100 g/d group (P < 0.01).

Damani JJ, Rogers CJ, Lee H, et al. J Nutr, 2024. PMID 38490532

2024 / Cohort studies, mechanistic experiments, and an intervention trial

Circulating xylitol was linked to 3-year MACE risk, and xylitol consumption enhanced platelet responsiveness in healthy volunteers.

In a discovery cohort of 1,157 patients undergoing elective diagnostic cardiac evaluations, circulating levels of a polyol tentatively assigned as xylitol were associated with incident 3-year MACE risk. In a validation cohort of 2,149 patients, xylitol was confirmed to associate with incident MACE risk (third vs. first tertile adjusted HR 1.57, 95% CI 1.12-2.21, P < .01). Complementary mechanistic assays indicated xylitol enhanced platelet reactivity and in vivo thrombosis. Furthermore, an intervention in 10 healthy volunteers showed that consuming a xylitol-sweetened drink markedly raised plasma levels and enhanced multiple measures of platelet responsiveness in all subjects.

Witkowski M, Nemet I, Li XS, et al. Eur Heart J, 2024. PMID 38842092

2023 / Single-center, prospective, randomized, single-blind clinical trial

Rosuvastatin reduced LDL-C significantly more than placebo and six dietary supplements, none of which lowered LDL-C compared with placebo.

Adults with an increased 10-year risk of ASCVD were randomized to rosuvastatin 5 mg daily, placebo, fish oil, cinnamon, garlic, turmeric, plant sterols, or red yeast rice for 28 days. A total of 190 participants completed the trial. Rosuvastatin achieved a greater percent LDL-C reduction than all supplements and placebo (P < 0.001), with a -35.2% difference compared with placebo (95% CI: -41.3% to -29.1%; P < 0.001). None of the dietary supplements demonstrated a significant decrease in LDL-C compared with placebo, and adverse event rates were similar across groups.

Laffin LJ, Bruemmer D, Garcia M, et al. J Am Coll Cardiol, 2023. PMID 36351465

2023 / Randomized, double-blind, placebo-controlled add-on trial

In patients with uncontrolled type 2 diabetes, add-on spirulina platensis significantly reduced HbA1c, fasting glucose, and improved lipid profiles.

Sixty patients with uncontrolled type 2 diabetes mellitus were randomized to receive either Spirulina platensis (2 g/day) or placebo for three months alongside usual metformin therapy. Compared to baseline, S. platensis supplementation resulted in significant reductions in HbA1c (decrease of 1.43, p < 0.001) and FBS (decrease of 24.94 mg/dL, p < 0.001). Total cholesterol dropped by 41.36 mg/dL, LDL-C dropped by 38.4 mg/dL, and triglycerides were significantly lower than controls (p < 0.001), while HDL-C showed a marginal increase (increase of 3 mg/dL, p < 0.001). No adverse events were reported.

Karizi SR, Armanmehr F, Azadi HG, et al. Phytother Res, 2023. PMID 36598187

2023 / Randomized controlled trial

A 16-week plant-based diet, exercise, and stress-reduction program significantly improved WOMAC scores and metabolic markers in metabolic syndrome osteoarthritis.

Sixty-six patients with hip or knee metabolic syndrome-associated osteoarthritis were randomized to a 16-week multidisciplinary lifestyle program (whole food plant-based diet, physical activity, stress management) plus usual care, or usual care alone. After 16 weeks, the intervention group had an 11-point larger improvement in WOMAC score compared to controls (95% CI 6-16; p = 0.0001). The intervention group also lost more weight (-5 kg), fat mass (-4 kg), and waist circumference (-6 cm), and had greater improvements in PROMIS fatigue, pain interference, CRP, HbA1c, fasting glucose, and LDL.

Walrabenstein W, Wagenaar CA, van de Put M, et al. Osteoarthritis Cartilage, 2023. PMID 37328047

2022 / 8-week single-blinded randomized controlled trial

In people with cardiovascular risk factors, dried purple-black barberry consumption significantly lowered plasma lipids and CRP compared to placebo.

An 8-week single-blind randomized controlled trial evaluated the effects of 10 g/day dried barberry versus placebo in 84 participants with cardiovascular risk factors. Body weight, BMI, physical activity, and dietary intake did not differ between groups. After adjusting for baseline values, the barberry group showed significant decreases compared to placebo in TG (p < 0.001), TC (p = 0.011), LDL-C (p = 0.015), sd-LDL-C (p = 0.019), non-HDL-C (p = 0.004), TC/HDL-C (p = 0.039), and CRP (p = 0.020).

Emamat H, Zahedmehr A, Asadian S, et al. BMC Complement Med Ther, 2022. PMID 35255880

2022 / Randomized, double-blind, placebo-controlled, 2-by-2 factorial trial

Cocoa extract supplementation did not significantly reduce total cardiovascular events in older adults, but reduced cardiovascular death by 27%.

The COSMOS trial randomized 21,442 older US adults to a cocoa extract supplement (500 mg flavanols/d, including 80 mg epicatechin) or placebo for a median follow-up of 3.6 years. Cocoa extract did not significantly reduce confirmed total cardiovascular events (410 vs 456 participants; HR: 0.90; 95% CI: 0.78, 1.02; P = 0.11). However, secondary endpoints showed a significant reduction in cardiovascular death (HR: 0.73; 95% CI: 0.54, 0.98), while per-protocol analysis indicated a lower risk of total events (HR: 0.85; 95% CI: 0.72, 0.99). All-cause mortality (HR: 0.89; 95% CI: 0.77, 1.03) and other individual endpoints were not significantly different, and no safety concerns were observed.

Sesso HD, Manson JE, Aragaki AK, et al. Am J Clin Nutr, 2022. PMID 35294962

2022 / Randomized controlled trial

Consuming 40 g of brown or golden flaxseed daily for 12 weeks reduced intestinal permeability and endotoxemia in perimenopausal overweight women.

Thirty perimenopausal overweight women were divided into a control group, brown flaxseed group, and golden flaxseed group, with the intervention groups consuming 40 g of flaxseed daily for 12 weeks. Intestinal permeability was significantly reduced in the flaxseed groups, with a smaller delta of lactulose/mannitol ratio (p ≤ 0.05). LPS levels were reduced in both flaxseed groups, while LDL decreased in the golden flaxseed group (p ≤ 0.05). Flaxseed consumption did not change oxidative stress markers or fasting glycaemia.

Sant'Ana CT, Amorim AD, Gava AP, et al. Int J Food Sci Nutr, 2022. PMID 35311432

2022 / Randomized controlled trial extension

One year after stopping semaglutide and lifestyle intervention, participants regained two-thirds of their prior weight loss.

In the STEP 1 trial extension, 327 participants who completed 68 weeks of once-weekly semaglutide 2.4 mg or placebo plus lifestyle intervention were followed for 52 weeks after discontinuing all treatments. Mean weight loss from week 0 to 68 was 17.3% (SD: 9.3%) with semaglutide and 2.0% (SD: 6.1%) with placebo. Following withdrawal, semaglutide participants regained 11.6 percentage points (SD: 7.7) of lost weight by week 120, yielding a net weight loss of 5.6% (SD: 8.9%) from week 0 to 120, while placebo participants regained 1.9 percentage points (SD: 4.8; net loss 0.1%). Cardiometabolic improvements seen at week 68 with semaglutide reverted toward baseline at week 120 for most variables.

Wilding JPH, Batterham RL, Davies M, et al. Diabetes Obes Metab, 2022. PMID 35441470

1995 / Narrative review

Androgen excess in women is linked to risks such as cardiovascular disease and insulin resistance, with risk reduction including weight maintenance and exercise.

This review details the clinical manifestations and health risks of androgen excess in women, including hirsutism, central obesity, cardiovascular disease, intravascular thrombosis, and insulin resistance. It highlights that prompt recognition and an interdisciplinary approach can reduce associated morbidity and mortality. Recommended risk reduction strategies encompass maintaining ideal weight, exercise, smoking cessation, treating dyslipidemias, low-dose aspirin, and appropriate hormone therapies.

Derman RJ Am J Med, 1995. PMID 7825634

1995 / Narrative review

Excess visceral fat and hypercortisolism are linked to metabolic syndrome abnormalities and cardiocerebrovascular and diabetes risk.

This review discusses the relationship between hypercortisolism, stress axis activation, and obesity. Visceral fat is most strongly associated with morbidity and mortality from cardiocerebrovascular disease and diabetes, as well as metabolic syndrome (hypertension, hyperlipidemia, hyperinsulinemia, and insulin resistance). Metabolic syndrome is also present in Cushing's syndrome, characterized by primary hypercortisolism and profound visceral adiposity. Chronic physical or psychological stress impacts body composition through glucocorticoids, significantly affecting survival.

Shows an association, not proof of cause and effect.

Peeke PM, Chrousos GP Ann N Y Acad Sci, 1995. PMID 8597440

1994 / Narrative review

Dietary substances beyond classic fats may affect coronary heart disease risk through diverse biological mechanisms.

This review evaluates evidence that diverse dietary components beyond medium-chain fatty acids, soluble fiber, and cholesterol can influence coronary heart disease risk without directly altering LDL cholesterol. Highlighted substances include phytosterols, tocotrienols, arginine, and antioxidant vitamins. The review addresses dietary effects on HDL cholesterol, triglycerides, oxidized LDL, prostaglandins, and endothelium-derived relaxing factor, incorporating epidemiological associations from the Adventist Health Study.

Fraser GE Am J Clin Nutr, 1994. PMID 8172111

1992 / Narrative review

A review discusses the potential of beta-carotene, nutrition, supplements, and lifestyle in preventing cancer and cardiovascular disease.

Cancer and cardiovascular disease remain the top two killer diseases in most developed countries. The author discusses justified hope that beta-carotene will be shown to be efficacious in preventing or delaying the onset of these chronic diseases. Chronic disease prevention through improved nutrition, judicious supplement use, and better lifestyles is anticipated to become increasingly important as the population aged over 65 years expands.

Muggli R J Nutr Sci Vitaminol (Tokyo), 1992. PMID 1297812

1992 / Narrative review

An evolutionary paradigm suggests dietary fat should be 20-25% of energy and total serum cholesterol below 150 mg/dL.

This review evaluates contemporary human lipid physiology in the context of evolutionary history and data from recently studied hunter-gatherers. The author notes that human physiology was selected for a nutritional pattern with much less fat, particularly less saturated fat, than current recommendations reflect. Based on this evolutionary paradigm, the paper suggests that fats should comprise 20-25% of total energy intake, the ratio of polyunsaturated to saturated fat should exceed 1.0, and total serum cholesterol levels should be below 150 mg/dL (approximately 4 mM/L).

Eaton SB Lipids, 1992. PMID 1435101

1989 / Narrative review

Taurine is a conditionally essential nutrient with preliminary evidence for potential roles in heart disease, acute hepatitis, cystic fibrosis, and myotonia.

This review examines taurine's physiological roles, including bile salt synthesis, modulation of calcium flux and neuronal excitability, osmoregulation, detoxification, and membrane stabilization. Taurine is found in animal-source foods but not plants, and concerns over endogenous synthesis adequacy have led to formula supplementation for neonates. Retinal dysfunction has been noted in taurine-deficient animals and in children receiving long-term total parenteral nutrition. Preliminary evidence indicates possible roles for taurine administration in congestive heart disease, acute hepatitis, cystic fibrosis, and myotonia, though further studies are required before routine advocacy.

Kendler BS Prev Med, 1989. PMID 2496406

1989 / Narrative review

Upper-body obesity, commonly induced by caloric excess, is linked to hyperinsulinemia, hypertension, diabetes, and hypertriglyceridemia.

This review examines evidence on the role of upper-body obesity in mediating cardiovascular risk factors through hyperinsulinemia. Upper-body predominance of weight connects hypertension, diabetes, and hypertriglyceridemia, even without significant overall obesity. The author notes that caloric excess in the presence of androgens typically induces upper-body obesity, highlighting the need to prevent it or provide treatments that do not exacerbate hyperinsulinemia.

Kaplan NM Arch Intern Med, 1989. PMID 2662932

1988 / Narrative review

A high-carbohydrate vegetarian diet can help endurance athletes maximize glycogen stores while meeting nutritional needs and reducing coronary risk factors.

This review notes that confounding factors such as dietary macronutrient levels, training habits, and lifestyle patterns complicate interpreting the specific effects of diet on endurance performance. Athletes undergoing heavy training are urged to consume 70% of calories as carbohydrates to maximize glycogen stores, which can be facilitated by emphasizing high-carbohydrate plant foods over animal products. Although restrictive vegetarian diets may increase the risk of iron deficiency or amenorrhea in some female athletes, a balanced vegetarian diet meets all known nutritional needs and provides an added reduction in coronary risk factors.

Nieman DC Am J Clin Nutr, 1988. PMID 3046304

1986 / Literature review

Southwestern Hispanics had health indicators more similar to other whites than blacks despite lower socioeconomic status, though disadvantaged for diabetes.

A review of literature assessed the health status of southwestern Hispanics, mostly Mexican Americans, across multiple indicators including mortality, cardiovascular diseases, cancer, and diabetes. The health status of Hispanics in the Southwest was found to be more similar to that of other whites than to blacks, despite their socioeconomic status being closer to blacks. This pattern was observed for infant mortality, life expectancy, cardiovascular mortality, cancer mortality, and functional health, though Hispanics were clearly disadvantaged regarding diabetes and infectious diseases. Potential explanatory factors discussed include cultural practices, family supports, selective migration, diet, and genetics.

Shows an association, not proof of cause and effect.

Markides KS, Coreil J Public Health Rep, 1986. PMID 3086917

1981 / Hypothesis paper

A paper hypothesizes that higher levels of stored iron account for the greater incidence of heart diseases in men and postmenopausal women.

A hypothesis is proposed that higher levels of stored iron explain the greater incidence of heart diseases in men and postmenopausal women compared with premenopausal women. The author supports this with observations of myocardial failure in iron storage disease, age-related accumulation of stored iron in men, accumulation of stored iron after menopause to levels seen in men, and the rarity of heart diseases of affluence among often iron-deficient impoverished populations. Regular phlebotomy is proposed as an experimental system to test the hypothesis and as a preventive therapy if the hypothesis is confirmed.

Sullivan JL Lancet, 1981. PMID 6112609

1981 / Literature review and ecological correlation update

International data linked animal foods and fat to colon and breast cancer deaths, while vegetable intake was inversely linked to colon cancer rates.

The literature on international correlations between dietary items and cancer frequency was reviewed alongside an updated correlation of cancer mortality and food consumption data. Strong and consistent correlations were noted between death rates of colon and breast cancers and per capita consumption of total fat and animal-derived nutrients (especially beef, pork, eggs, and milk), with less consistent links for prostate, ovary, and endometrial cancers. In New Orleans autopsy populations, correlations were reported between precursor lesions of coronary heart disease and colon cancer. Colon cancer rates correlated negatively with vegetable consumption and stool weight.

Shows an association, not proof of cause and effect.

Correa P Cancer Res, 1981. PMID 6266659

1979 / Narrative review / hypothesis paper

Atherogenesis may occur during the postprandial period via the arterial uptake of chylomicron remnants from a cholesterol-rich diet.

This article evaluates the hypothesis that plasma chylomicrons from a cholesterol-rich diet are atherogenic. Evidence indicates that in both humans and experimental animals, chylomicron remnants and low-density lipoproteins are taken up by arterial cells. The author proposes that in individuals without familial hyperlipoproteinemia, atherogenesis may be a postprandial phenomenon, highlighting the urgent need for lipoprotein studies following test meals containing fat and cholesterol.

Zilversmit DB Circulation, 1979. PMID 222498